BiotechTube

Deucravacitinib + Placebo

Phase 2Withdrawn
0 views this week 0 watching💤 Quiet
Interest: 27/100
27
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Papulopustular Rosacea

Conditions

Papulopustular Rosacea

Trial Timeline

Nov 1, 2024 → Jan 1, 2026

NCT ID
NCT06532136

About Deucravacitinib + Placebo

Deucravacitinib + Placebo is a phase 2 stage product being developed by Bristol Myers Squibb for Papulopustular Rosacea. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT06532136. Target conditions include Papulopustular Rosacea.

What happened to similar drugs?

3 of 13 similar drugs in Papulopustular Rosacea were approved

Approved (3) Terminated (1) Active (9)
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄Topical Dapsone 5% Gel + oral antibioticsBristol Myers SquibbPhase 3
✅Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
✅Azelaic Acid foam 15%BayerApproved
✅azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
🔄Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3

Hype Score Breakdown

Clinical
12
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (4)

NCT IDPhaseStatus
NCT06532136Phase 2Withdrawn
NCT05997277Phase 2Terminated
NCT06042920ApprovedTerminated
NCT04857034Phase 2Active

Competing Products

18 competing products in Papulopustular Rosacea

See all competitors
ProductCompanyStageHype Score
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
29
Topical Dapsone 5% Gel + oral antibioticsBristol Myers SquibbPhase 3
40
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
40
Azelaic Acid foam 15%BayerApproved
40
Azelaic acid + Vehicle foamBayerPhase 2
32
Azelaic acid foam 15% + Vehicle foamBayerPhase 2
32
azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
40
Azelaic Acid Foam + Azelaic Acid GelBayerPhase 1
26
Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3
37
Encapsulated Benzoyl Peroxide CreamSol-Gel TechnologiesPhase 1
19
S5G4T-1Sol-Gel TechnologiesPhase 3
22
S5G4T-1 + S5G4T-2Sol-Gel TechnologiesPhase 3
30
S5G4T-1 + S5G4T-2Sol-Gel TechnologiesPhase 3
30
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
30
FMX103 1.5%Vyne TherapeuticsPhase 3
30
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
30